×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: Tau Pathology
mechanism
3,310 words
KG: ent-prot-1e3aff6a
2026-03-23
kind:
section:
state:published
Contents
Tau Pathology
⚙
Mechanism Info
Name
Tau Pathology
Summary
# Tau](entities/tau-protein](entities/tau-protein-protein)-protein) Patholog
Knowledge Graph
Related Hypotheses (30)
Bacterial Enzyme-Mediated Dopamine Precursor Synthesis
Score: 0.36
Closed-loop transcranial focused ultrasound to restore hippo
Score: 0.71
Multi-Target Hypothesis: Aβ-Induced Cholinergic Damage is Pa
Score: 0.70
Closed-loop tACS targeting EC-II SST interneurons to block t
Score: 0.70
Closed-loop focused ultrasound targeting EC-II SST interneur
Score: 0.70
Hippocampal CA3-CA1 synaptic rescue via DHHC2-mediated PSD95
Score: 0.69
Gamma entrainment therapy to restore hippocampal-cortical sy
Score: 0.68
Closed-loop tACS targeting EC-II PV interneurons to suppress
Score: 0.67
Closed-loop tACS targeting EC-II parvalbumin interneurons to
Score: 0.66
Selective Acid Sphingomyelinase Modulation Therapy
Score: 0.65
Closed-loop transcranial alternating current stimulation to
Score: 0.64
Closed-loop tACS targeting entorhinal cortex layer II SST in
Score: 0.62
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflam
Score: 0.62
APOE-Dependent Autophagy Restoration
Score: 0.61
Closed-loop transcranial focused ultrasound targeting EC-II
Score: 0.61
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61
Senescence-Activated NAD+ Depletion Rescue
Score: 0.60
Microglial AIM2 Inflammasome as the Primary Driver of TDP-43
Score: 0.60
Multi-Modal Stress Response Harmonization
Score: 0.60
Prefrontal sensory gating circuit restoration via PV interne
Score: 0.59
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.59
Microbial Inflammasome Priming Prevention
Score: 0.58
Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neu
Score: 0.58
Closed-loop tACS targeting EC-II PV interneurons to enhance
Score: 0.58
GluN2B-Mediated Thalamocortical Control of Glymphatic Tau Cl
Score: 0.58
TREM2-Mediated Cholesterol Dysregulation in Microglial Senes
Score: 0.57
CYP46A1 Gene Therapy for Age-Related TREM2-Mediated Microgli
Score: 0.57
Closed-loop focused ultrasound targeting EC-II PV interneuro
Score: 0.57
Optogenetic restoration of hippocampal gamma oscillations vi
Score: 0.57
Show 25 more
Related Analyses (30)
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Is disrupted sleep a cause or consequence of neurodegenerati
neurodegeneration · failed
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · failed
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Lipid metabolism dysregulation and membrane integrity in Alz
neurodegeneration · completed
Investigate prion-like spreading of tau pathology through co
neurodegeneration · failed
Lysosomal dysfunction and cathepsin leakage in Alzheimer dis
neuroscience · failed
Trans-synaptic tau spreading and propagation mechanisms in A
neuroscience · failed
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · completed
Does tau aggregation specifically cause PS externalization i
neurodegeneration · failed
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Circuit-level neural dynamics in neurodegeneration
neuroscience · archived
Epigenetic reprogramming in aging neurons
neurodegeneration · archived
Show 25 more
Related Experiments (30)
Brain Connectivity-Targeted tACS Trial in Early AD
clinical · proposed · Score: 0.95
Cell type-specific P2rx7 deletion in microglia vs astrocytes
validation · proposed · Score: 0.85
s:** - Test whether HCN1 knockout specifically in EC layer I
falsification · proposed · Score: 0.46
Proposed experiment from debate on Synaptic pruning by micro
falsification · proposed · Score: 0.46
s:** - Test MCU overexpression specifically in layer II neur
falsification · proposed · Score: 0.46
s:** - Test tau spreading in AQP4 knockout vs wild-type mice
falsification · proposed · Score: 0.46
s:** - Compare tau strain spreading in EXT1/EXT2 conditional
falsification · proposed · Score: 0.46
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.46
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.46
Why Does Amyloid Removal Only Slow Decline 27%? — Mechanisti
clinical · proposed · Score: 0.46
Mechanism: Why Does Amyloid Removal Only Slow Decline 27%?
clinical · proposed · Score: 0.46
Animal Model Comparison for Neurodegenerative Disease Therap
clinical · proposed · Score: 0.46
Anti-Tau Immunotherapy Dosing Optimization
clinical · proposed · Score: 0.46
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.46
Autophagy Enhancement Drug Screening for Neurodegeneration
clinical · proposed · Score: 0.46
Biomarker-Guided Sequential Therapy Selection in Alzheimer's
clinical · proposed · Score: 0.46
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.46
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.46
Circadian-Vascular-Metabolic Syndrome (CVMS) Intervention Tr
clinical · proposed · Score: 0.46
Tau Co-Pathology in DLB Clinical Heterogeneity
clinical · proposed · Score: 0.46
Down Syndrome Alzheimer's Disease: Mechanisms and Therapeuti
clinical · proposed · Score: 0.46
Epigenetic Clocks in Neurodegeneration — Causal Drivers or P
validation · proposed · Score: 0.46
Metal Ion Homeostasis Dysregulation in Alzheimer's Disease
validation · proposed · Score: 0.46
Migraine Cortical Hyperexcitability and Alzheimer's Disease
clinical · proposed · Score: 0.46
Sleep Disruption and Alzheimer's Disease — mechanism and int
clinical · proposed · Score: 0.46
Tau Pathology Initiation Zone Identification
clinical · proposed · Score: 0.46
Tau Spreading Network Mapping via Spatial Transcriptomics in
clinical · proposed · Score: 0.46
Biomechanical Impact Profiles and Chronic Traumatic Encephal
clinical · proposed · Score: 0.46
TDP-43 PET Ligand Development for FTD and ALS
clinical · proposed · Score: 0.46
Tau ASO Therapy
validation · proposed · Score: 0.46
Show 25 more